View drug registration information details.
Items | Registration information |
ID | 71 |
No | 71 |
Brand Name | NERVICA 75 |
Ingredients | PREGABALIN 75 MG |
Dosage Form | CAPSULE |
Primary Packaging | ALU-PVC/PVDC |
Storage | STORE AT TEMPERATURE NOT MORETHAN 30 C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 4 X 14'S |
Dispensing Category | PRESCRIPTION ONLY |
ATC Classification | N03AX16 |
Pharmaceutical Class | ANTIEPILEPTIC |
Indications | FOR THE TREATMENT OF PERIPHERAL AND CENTRAL NEUROPATHIC PAIN IN ADULTS, AS ADJUNCTIVE THERAPY IN ADULTS WITH PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION, FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER IN ADULT |
Contraindications | HYPERSNESITIVITY TO THE ACTIVE INGREDIENT OR TO ANY OF THE EXCIPIENT |
Side Effects | APPETITE CHANGE, BLURRED VISION, CONFUSION, CONSTIPATION, DIPLOPIA, DISTURBANCE IN MUSCLE CONTROL AND MOVEMENT, DIZZINESS, DROWSINESS, DRY MOUTH, EUPHORIA, FLATULENCE, IMPAIRED ATTENTION, IMPAIRED MEMORY, INSOMNIA, IRRITABILITY, MALAISE, EDEMA, PARESTHESIA, SEXUAL DYSFUNCTION, SPEECH DISORDER, VISUAL DISTURBANCE, VISUAL FIELD DEFECTS, VOMITING, WEIGHT GAIN |
Unit Price | |
EDL |
Yes |
Description | OPAQUE RED/WHITE CAPSULE NO.4 WITH PRINT 75 PRE IN BLACK COLOR |
Note | |
License Owner | AI KEN PHARMA CO., LTD |
Manufacturer | UNISON LABORATORIES CO., LTD |
Country | THAILAND |
Import Registration No | 1A 68/60(NG) |
Import Registration Date | 22-11-2017 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2020-09-15 |
FDD Registration No | 10 I 5291/22 |
FDD Registration Date | 2022-10-14 |
Expiry Date | 2025-10-13 |
Back to drug list
|